Hospital compounding to face shortage: A case study of the development of a lopinavir-ritonavir oral suspension during the first wave of SARS-COV-2 in France

The potential usefulness of lopinavir-ritonavir on Covid 19 infection during the first wave of contamination in France had boosted Kaletra® syrup prescription to the point of causing its national shortage. In the intensive care units of Parisian hospitals in charge of patients with life-threatening...

Descripción completa

Detalles Bibliográficos
Autores principales: Secretan, P.-H., Thirion, O., Vieillard, V., Saunier, J., Razazi, K., Paul, M., Do, B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Académie Nationale de Pharmacie. Published by Elsevier Masson SAS. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461001/
https://www.ncbi.nlm.nih.gov/pubmed/34563517
http://dx.doi.org/10.1016/j.pharma.2021.09.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461001/
https://www.ncbi.nlm.nih.gov/pubmed/34563517
http://dx.doi.org/10.1016/j.pharma.2021.09.002

Ejemplares similares